13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 5 of 5

Page 5 of 5 – SEC Filing

CUSIP No . 713661502   Page 6 of 7
Item 5. Ownership of Five Percent or Less of a Class.
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following
   
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Item 8. Identification and Classification of Members of the Group.
Item 9. Notice of Dissolution of Group.
Item 10. Certification.

By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §
240.14a-11.

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true, complete and correct.

Date: July 20, 2017
Signature: /s/  Prasad Phatak
Name:

TAPPAN STREET PARTNERS, LLC

Date: July 20, 2017
By: /s/ Prasad Phatak
Name:
Title: Managing Member

Follow Avid Bioservices Inc. (NASDAQ:CDMO)

Page 5 of 5